| Massive accumulation of neutral lipids in cells conditionally transformed by an activated H-ras oncogene. | None |
| Bradykinin-induced oscillations of cell membrane potential in cells expressing the Ha-ras oncogene. | None |
| Correlation of growth capacity of cells in hard agarose with successful transfection by the activated c-Ha-ras oncogene and in vivo proliferative capacity at metastatic sites. | None |
| Oncogenic K-Ras and its effector Raf1 convert death receptors into invasion-inducing receptors by suppressing the ROCK/LIM kinase pathway, and this is essential for K-Ras/Raf1-driven metastasis formation. | None |
| JNK2 collaborates with other oncogenes, such as Ras, at multiple molecular levels to promote tumorigenesis | None |
| Ras induces ARC in epithelial cancers, and ARC plays a role in the oncogenic actions of Ras | None |
| Costello syndrome is a rasopathy caused by germline mutations in the proto-oncogene HRAS. | None |
| Wnt-5a is involved during oncogenic H-Ras/TGF-beta-mediated epithelial-mesenchymal transition | None |
| Inactivation of the p53 tumor suppressor gene and activation of the Ras oncogene: cooperative events in tumorigenesis. | None |
| Recent studies on the cooperative molecular mechanisms by which p53 inactivation and oncogenic Ras converge to enhance tumorigenesis. | None |
| The Ras oncogene signals centrosome amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2. | None |
| Histopathology of salivary and mammary gland tumors in transgenic mice expressing a human Ha-ras oncogene. | None |
| Quantitation of mRNA and protein products of the Ha-ras-1 proto-oncogene. | None |
| The ability to interfere with the expression and oncogenic potential of H-Ras provides a new face of the suppressor role exhibited by endoglin in H-Ras-driven carcinogenesis. | None |
| Prolongation of the yeast life span by the v-Ha-RAS oncogene. | None |
| Ha-ras oncogene regulates morphogenesis, tumorigenesis, and metastasis through suppressing nm23 expression and modulation of immune cell function. | None |
| Denaturing gradient gel electrophoretic analysis of the human cHa-ras1 proto-oncogene. | None |
| Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene. | None |
| Effects of specific fatty acids on cell transformation induced by an activated c-H-ras oncogene. | None |
| Attenuation of glucocorticoid receptor levels by the H-ras oncogene. | None |